Open AccessPhase 3 study (Study 309/KEYNOTE-775) of lenvatinib plus pembrolizumab vs treatment of physician's choice in advanced endometrial cancer: Japanese subset
Author(s) -
Mayu Yunokawa,
Keiichi Fujiwara
Publication year - 2021
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3802/jgo.2021.32.s1.bo3
Subject(s) - lenvatinib , pembrolizumab , medicine , oncology , cancer , gynecology , immunotherapy , thyroid cancer